Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
Clinical trial NCT01028053 · COMPLETED
Trial details
- NCT number
- NCT01028053
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-01-01
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.